Investor Materials
BioShake is a new GLP-1 support category with a daily milkshake shot designed for simpler, more consistent use than pills or injections. The product combines four clinically studied active ingredients in a pre-measured, portable format that users just add water to, shake, and drink.
The business is designed as a subscription-first DTC model, with affiliate-led customer acquisition, lean third-party operations, and AI-native execution. BioShake is currently raising $250,000 on a post-money SAFE at a $2.5M valuation cap to support commercial launch.
Download the Executive Summary or Pitch Deck for an overview of the market, product, clinical rationale, business model, and funding round.
Additional supporting materials are available for qualified investors upon request.
BioShake is a product of Bala Ingredients Inc
Frequently Asked Questions
BioShake is a daily GLP-1 support milkshake shot for women who want a simpler, more enjoyable alternative to pills and injections
The GLP-1 market is exploding, but the current consumer experience is still dominated by formats many people find unpleasant, inconvenient, or hard to sustain
BioShake turns GLP-1 support into a portable, drinkable ritual: just add water, shake, and drink
BioShake combines four clinically studied active ingredients, supported by human research across appetite, glucose, weight, and metabolic health.
Clinical studies and trials documentation are available upon request for diligence.